- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 189-203 of
646 results
2066 Exhibit: Kaken Exhibit 2066
Document
IPR2017-00190, No. 2066-112 Exhibit - Kaken Exhibit 2066 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2035 Exhibit: Kaken Exhibit 2035
Document
IPR2017-00190, No. 2035-82 Exhibit - Kaken Exhibit 2035 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1016 Exhibit: Stuttgen, G and Bauer, E, Mycoses, 252 74 80 1992
Document
IPR2017-00190, No. 1016-16 Exhibit - Stuttgen, G and Bauer, E, Mycoses, 252 74 80 1992 (P.T.A.B. Nov. 2, 2016)
|
|
Cite Document
1604 Exhibit: Exhibit 1604a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1604-338 Exhibit - Exhibit 1604a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31,...
|
|
Cite Document
1529 Exhibit: Thomas Reuters StreetEvents, Edited Transcript, VRXTO Q3 2015 V...
Document
IPR2017-00190, No. 1529-178 Exhibit - Thomas Reuters StreetEvents, Edited Transcript, VRXTO Q3 2015 Valeant Pharmaceuticals International Inc Earnings Call (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1633 Exhibit: Valeant, Woes Rising, Backs Away From Boldness to Calm Investors
Document
IPR2017-00190, No. 1633-282 Exhibit - Valeant, Woes Rising, Backs Away From Boldness to Calm Investors (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1635 Exhibit: Pricing and reimbursement in US pharmaceutical markets
Document
IPR2017-00190, No. 1635-284 Exhibit - Pricing and reimbursement in US pharmaceutical markets (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1045 Exhibit: Acrux DDS Pty Ltd Corporate Website
Document
IPR2017-00190, No. 1045-45 Exhibit - Acrux DDS Pty Ltd Corporate Website (P.T.A.B. Nov. 2, 2016)
|
|
Cite Document
2111 Exhibit: Kaken Exhibit 2111
Document
IPR2017-00190, No. 2111-342 Exhibit - Kaken Exhibit 2111 (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
1603 Exhibit: Exhibit 1603a Valeant Pharmaceuticals International, Inc, US Securit...
Document
IPR2017-00190, No. 1603-337 Exhibit - Exhibit 1603a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31,...
|
|
Cite Document
1668 Exhibit: Declaration of Aydin H Harston in Support of Supplemental Evidence ...
Document
IPR2017-00190, No. 1668-323 Exhibit - Declaration of Aydin H Harston in Support of Supplemental Evidence Served May 30, 2017, with attached exhibits (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
1623 Exhibit: Exhibit 1623a ¿¿¿An Exploratory Study to Improve Sales Operations W...
Document
IPR2017-00190, No. 1623-340 Exhibit - Exhibit 1623a ¿¿¿An Exploratory Study to Improve Sales Operations When Selling Multiple Prescription Drugs,¿¿¿ JC Yi, M Zhou, T Park, Journal of Supply...
|
|
Cite Document
1513 Exhibit: Exhibit 1513a Tadashi Arika et al, Nishi Nihon Journal of Dermatology...
Document
IPR2017-00190, No. 1513-328 Exhibit - Exhibit 1513a Tadashi Arika et al, Nishi Nihon Journal of Dermatology, 52 3 545 549 1990 (P.T.A.B. Jan. 5, 2018)
|
|
Cite Document
1672 Exhibit: Declaration of Lisa N Phillips in Support of Petitioners¿¿¿ Response to ...
Document
IPR2017-00190, No. 1672-327 Exhibit - Declaration of Lisa N Phillips in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan....
|
|
Cite Document
1561 Exhibit: A Realistic Approach to the Obviousness of Inventions
Document
IPR2017-00190, No. 1561-210 Exhibit - A Realistic Approach to the Obviousness of Inventions (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
